Faktor risiko transformasi hemoragik pada pasien stroke infark
https://doi.org/10.22146/bns.v18i2.54994 Adika Mianoki(1), Ismail Setyopranoto(2*), Mochammad Was’an(3)
(1) KSM Saraf RSUP Soeradji Tirtonegoro, Klaten
(2) Departemen Neurologi Fakultas Kedokteran, Kesehatan Masyarakat dan Keperawatan, Universitas Gadjah Mada, Yogyakarta
(3) Departemen Neurologi Fakultas Kedokteran, Kesehatan Masyarakat dan Keperawatan, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author
Abstract
Transformasi hemoragik dari infark serebral merupakan kejadian yang umum dan berpotensi serius terjadi setelah stroke iskemia akut. Tingkat keparahan perdarahan dapat berkisar dari beberapa petekia sampai hematoma ukuran besar yang menimbulkan efek desak ruang. Patogenesis transformasi hemoragik belum begitu jelas, meskipun iskemia dan reperfusi telah dianggap menyebabkan gangguan sawar darah otak yang menyebabkan ekstravasasi darah. Pada tingkat molekuler, radikal bebas dan enzim proteolitik (metaloproteinase) dapat menyebabkan kerusakan jaringan.
Beberapa kondisi merupakan faktor risiko terjadinya transformassi hemoragik. Faktor-faktor yang telah diketahui merupakan prediktor potensial untuk trombolisis yang berkaitan dengan transformasi hemoragik dapat dikategorikan menjadi faktor klinik, biokimiawi, dan radiologis. Dengan mengendalikan atau memonitor faktor-faktor tersebut sedini mungkin diharapkan bisa menurunkan kejadian transformasi hemoragik pada pasien stroke infark.
Telah terdapat algoritma yang disarankan untuk pengelolaan perdarahan intraserebral spontan setelah trombolisis intravena untuk stroke iskemia akut, akan tetapi algoritma ini hanya berbasis empiris bukan data. Penelitian lebih lanjut diperlukan untuk menentukan strategi pengelolaan yang optimal.
Keywords
Full Text:
PDFReferences
Thanvi BR, Treadwell S & Robinson T. Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy : classification, pathogenesis and risk factors. Ann Transl Med. 2014;2(8): 81.
Cordonnie CR. Pathophysiology of Non-Traumatic Intracerebral Haemorrhage. In : Oxford Textbook of Stroke and Cerebrovascular Disease. Oxford: Oxford University Press; 2014.
Warach S, Latour LL. Evidence of reperfusion injury,exacerbated by thrombolytic therapy, in human focal brainischemia usinga novel imaging marker of early bloodbrain barrier disruption. Stroke. 2004;35:2659-2661.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous rt-PA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
Kase CS, Fulan AJ, Wechsler LR. Cerebral haemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology. 2001;57:1603-1610.
Larrue V, von Kummer RR, Muller A. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator : a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32:438-441.
Larrue V, von Kummer R, del Zoppo G. Hemorrhagic transformation in acute ischemic stroke. Potensial contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997;28:957-960.
Libman R, Kwiatkowski T. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry. Stroke. 2007;38:e88.
del Zoppo GJ, von Kummer R, Hamman GF. Ischaemic damage of brain microvessels; inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65:1-9.
Wang X, Lo EH. Triggers and mediators of haemorrhagic transformation in cerebral ischaemia. Mol Neurobiol. 2003;28:229-244.
Burggraf D, Trinkl A, Burk J. vascular Integrin immunoreactivity is selectively lost on capillaries during rat focal cerebral ischemia and reperfusion. Brain Res. 2008;1189:189-197.
Wagner S, Tagaya M, Koziol Ja. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin alpha 6 beta 4 during focal cerebral ischemia/reperusion. Stroke. 1997;28:858-865.
Jorgensen L, Torvik A. ischaemic cerebrovascular disease in an autopsy series, 2:prevalence, location, pathogenesis, and clinical course of cerebral infarcts. J Neurol Sci. 1969;9:285-320.
Trouillas P, Derex L, Philippeau F. Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases. Stroke. 2004;35:1323-1328.
Castellanos M, Leira R, Serena J. Plasma metalloproteinase-9 concentration predicts haemorrhagic transformation in acute ischaemic stroke. Stroke. 2003;34:40-46.
Khatri R, McKinney AM, Swenson B. Blood-brainbarrier, reperfusion injury, and hemorrhagic transformationin acute ischemic stroke. Neurology. 2012;79:S52-57.
Wang BG, Yang N, Lin M. Analysis of Risk Factorsof Hemorrhagic Transformation After Acute IschemicStroke: Cerebral Microbleeds Do Not Correlate withHemorrhagic Transformation. Cell Biochem Biophys. 2014;70:135-142.
Kerenyi L, Kardos L, Szász J. Factors inflencinghemorrhagic transformation in ischemic stroke:a clinicopathological comparison. Eur J Neurol. 2006;13:1251-1255.
Zhang J, Yi Yang, Huijie Sun, Yingqi Xing. Hemorrhagic transformation after cerebral infarction : current concepts and challenges. Annals of Translational Medicine. 2014;2(8):pp.1–7.
Campbell BC, Christensen S. Worse Stroke Outcome in Atrial Fibrillation is Explained by More Severe Hypoperfusion, Infarct Growth, and Hemorrhagic Transformation. Int J Stroke. 2013.
Kidwell CS, Saver JL, Carneado J. Predictors ofhemorrhagic transformation in patients receiving intraarterial thrombolysis. Stroke 2002;33:717-724.
Paciaroni M, Agnelli G, Corea F. Early hemorrhagic transformation of brain infarction: rate, predictive factors,and influence on clinical outcome: results of a prospective multi center study. Stroke. 2008;39:2249-56.
Tanne D, Kasner SE, Demchuk AM. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue palsminogen activator therapy for acute ischemic stroke in clinical practice: the Multicentre rt-PA Stroke Survey . Circulation. 2002;105:1679-1685.
Engelter ST, Soinne L, Ringleb P. IV thrombolysis and statins. Neurology .2011;77:888-895.
Prodan CI, Stoner JA, Cowan LD. Lower coatedplatelet levels are associated with early hemorrhagictransformation inpatients with non-lacunar braininfarction. J Thromb Haemost. 2010;8:1185-1190.
Bang OY, Saver JL, Kim SJ. Collateral flw avertshemorrhagic transformation after endovascular therapy foracute ischemic stroke. Stroke. 2011;42:2235-2239.
Pfeilschifter W, Spitzer D, Czech-Zechmeister B. Increased risk of hemorrhagic transformation in ischemicstroke occurringduring warfarin anticoagulation: anexperimental study in mice. Stroke. 2011;42:1116-1121.
Xing Y, Guo ZN, Yan S. Increased globulin and its association with hemorrhagic transformation in patientsreceiving intra-arterial thrombolysis therapy.NeurosciBull. 2014;30:469-476.
Jaillard A, Cornu C, Durieux A. Hemorrhagictransformation in acute ischemic stroke. The MAST-Estudy.Stroke. 1999;30:1326-1332.
Hacke W, Kaste M, Fieschi C. Intravenous thrombolysis with recombinant tissue plasmingen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
Cho BH, Kim JT, Chang J. Prediction ofhemorrhagic transformation in acute ischaemic strokeby micro- and macroalbuminuria after intravenousthrombolysis. Eur J Neurol. 2013;20:1145-1152.
Inzitari D, Giusti B, Nencini P. MMP9 variation afterthrombolysis is associated with hemorrhagic transformationof lesion and death. Stroke. 2013;44:2901-2903.
Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag. 2014;24(10):75–87.
Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd; 2014 [cited 2015Jan 31]. Available from: http://onlinelibrary.wiley.com.ezproxy.ugm.ac.id/doi/10.1002/14651858.CD000213.pub3/abstract
Fugate JE, Rabinstein AA. Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke. Mayo Clin Proc. 2014;1(89)(7):960–972.
DOI: https://doi.org/10.22146/bns.v18i2.54994
Article Metrics
Abstract views : 4805
| 
views : 11902
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Berkala NeuroSains
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.